These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 7700424)
1. [Development of extrarenal complications of chronic renal insufficiency in patients treated by peritoneal dialysis]. Simon P Nephrologie; 1995; 16(1):77-83. PubMed ID: 7700424 [TBL] [Abstract][Full Text] [Related]
2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159 [TBL] [Abstract][Full Text] [Related]
3. [Peritoneal dialysis in the aged]. Stojimirović B; Nesić V; Dimitrijević Z; Jovanović N Med Pregl; 1999; 52(9-10):369-74. PubMed ID: 10624386 [TBL] [Abstract][Full Text] [Related]
4. [Development of peritoneal dialysis at Rijeka Clinical Hospital Center]. Zivcić-Cosić S; Vlahović A; Grzetić M; Matić-Glazar D Acta Med Croatica; 2004; 58(3):215-20. PubMed ID: 15503685 [TBL] [Abstract][Full Text] [Related]
11. The treatment of anemia in peritoneal dialysis patients. Lacson E; Diaz-Buxo JA Clin Nephrol; 2001 Dec; 56(6):415-27. PubMed ID: 11770793 [TBL] [Abstract][Full Text] [Related]
12. The clinical effects of recombinant human erythropoietin for the treatment of anemia in end stage renal disease patients on dialysis. Uthayanaka Y; Jirajan B; Krairithichai U; Jantavanich N Southeast Asian J Trop Med Public Health; 1993 Sep; 24(3):577-82. PubMed ID: 8160072 [TBL] [Abstract][Full Text] [Related]
13. Peritoneal dialysis is the therapy of choice for end-stage renal disease patients with hereditary clotting disorders. Bajo MA; del Peso G; Jiménez V; Aguilera A; Villar A; Jiménez C; Selgas R Adv Perit Dial; 2000; 16():170-3. PubMed ID: 11045286 [TBL] [Abstract][Full Text] [Related]
14. Long-term low-dose calcitriol treatment in predialysis chronic renal failure: can it prevent hyperparathyroid bone disease? Nordal KP; Dahl E; Halse J; Attramadal A; Flatmark A Nephrol Dial Transplant; 1995; 10(2):203-6. PubMed ID: 7753453 [TBL] [Abstract][Full Text] [Related]
15. Morbidity and mortality of dialysis. NIH Consens Statement; 1993 Nov 1-3; 11(2):1-33. PubMed ID: 8004133 [TBL] [Abstract][Full Text] [Related]
17. [Role of peritoneal dialysis in the treatment of terminal chronic renal insufficiency. Survival of patients and method]. Ryckelynck JP; Hurault de Ligny B; Levaltier B; Cardineau E; Le Goff C; Batho JM Nephrologie; 1995; 16(1):85-92. PubMed ID: 7700425 [TBL] [Abstract][Full Text] [Related]
18. Past, present and future of end-stage renal disease therapy in the United States. Uribarri J Mt Sinai J Med; 1999 Jan; 66(1):14-9. PubMed ID: 9989100 [TBL] [Abstract][Full Text] [Related]
19. [Human recombinant erythropoietin in treatment of uremic anemia in children with continual ambulatory peritoneal dialysis]. Litwin M; Boguszewska-Baczkowska A; Jelonek A Pol Tyg Lek; 1994 Feb 7-14; 49(6-7):135-6. PubMed ID: 8090665 [TBL] [Abstract][Full Text] [Related]
20. [Cardiovascular calcification and accelerated atherosclerosis in chronic kidney disease]. Cozzolino M; Butti A; Chiarelli G; Rocca-Rey L; Santagostino G; Gallieni M; Brancaccio D Ital Heart J Suppl; 2005 Jan; 6(1):25-8. PubMed ID: 15776728 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]